Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel
Year: 2020
Type: article
Study design: Observational Study
Institutions: University of Florida, University of Florida Health Science Center, University of Catania, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Université Paris Descartes, Sorbonne Université, Hôpital Saint-Antoine, St. Antonius Ziekenhuis, German Centre for Cardiovascular Research, Ludwig-Maximilians-Universität München, Scripps Clinic
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Boehringer Ingelheim, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Sanofi, Medtronic, Gilead Sciences, CSL Behring, Boston Scientific Corporation, Medicines Company, Bayer Fund, ZonMw, Daiichi-Sankyo, Eisai, St. Jude Medical, Merck Sharp and Dohme
OpenAlex ID: W3010345443
